关注
Archan Chakraborty
Archan Chakraborty
Post Doctoral Researcher at Duke University
在 duke.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Regulation of CTP Synthase Filament Formation During DNA Endoreplication in Drosophila
PY Wang, WC Lin, YC Tsai, ML Cheng, YH Lin, SH Tseng, A Chakraborty, ...
Genetics 201 (4), 1511-1523, 2015
422015
Histidine-dependent protein methylation is required for compartmentalization of CTP synthase
WC Lin, A Chakraborty, SC Huang, PY Wang, YJ Hsieh, KY Chien, ...
Cell reports 24 (10), 2733-2745. e7, 2018
322018
Ubiquitination and filamentous structure of cytidine triphosphate synthase
LM Pai, PY Wang, WC Lin, A Chakraborty, CT Yeh, YH Lin
Fly 10 (3), 108-114, 2016
192016
SNAP29 mediates the assembly of histidine-induced CTP synthase filaments in proximity to the cytokeratin network
A Chakraborty, WC Lin, YT Lin, KJ Huang, PY Wang, IYF Chang, HI Wang, ...
Journal of cell science 133 (9), jcs240200, 2020
82020
Conserved chamber-specific polyploidy maintains heart function in Drosophila
A Chakraborty, NG Peterson, JS King, RT Gross, MM Pla, A Thennavan, ...
Development 150 (16), dev201896, 2023
62023
High-throughput tomographic fluorescence imaging with a synchronized camera array (Conference Presentation)
KC Zhou, J Jönsson, C Cook, KC Lee, X Yang, S Xu, J Bagwell, ...
High-Speed Biomedical Imaging and Spectroscopy VIII, PC123900C, 2023
12023
Tomographic behavioral tracking of freely-moving model organisms with a hemispheric Fourier light field microscope
KC Zhou, C Cook, A Chakraborty, J Jönsson, KC Lee, X Yang, S Xu, ...
Three-Dimensional and Multidimensional Microscopy: Image Acquisition and …, 2024
2024
Abstract P2003: Cardiomyocyte Polyploidy: Friend Or Foe?
A Chakraborty, M Wolf, D Fox
Circulation Research 133 (Suppl_1), AP2003-AP2003, 2023
2023
Drosophila CTP synthase regulates collective cell migration by controlling the polarized endocytic cycle
PY Wang, A Chakraborty, HJ Ma, JW Wu, ACC Jang, WC Lin, HW Pi, ...
Development 149 (16), dev200190, 2022
2022
STARTING DOSE SELECTION OF THE IL-1B INHIBITOR GEVOKIZUMAB FOR THE FIRST-IN-ONCOLOGY (FIO) PHASE I TRIAL.
X Wang, S Xu, M Marker, A Vaury, M Shilkrut, B Mookerjee, J Millholland, ...
CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S62-S62, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–10